Podcasts by Lupus Science and Medicine podcast

Challenging but achievable: reaching Low Lupus Disease Activity State (LLDAS) in childhood-onset SLE from 2022-04-06T08:05:20

Duane Peters from the Lupus Foundation of America talks to Dr Sylvia Kamphuis and Dr Javad Wahadat from the Erasmus Medical Center in Rotterdam in the Netherlands about aiming for a Low Lupus Disea...

Could a high fiber diet positively impact the gut microbiome of SLE patients? from 2022-02-24T10:12:31

Duane Peters from the Lupus Foundation of America interviews Professor Iryna Kulyk from Indiana University in the USA and Professor Martin Kriegel from the University of Münster in Germany and Yale...

A new biomarker for cognitive dysfunction in SLE? from 2022-01-27T14:08:37

Duane Peters from the Lupus Foundation of America interviews Dr Erik Anderson and Dr Meggan Mackay from the Feinstein Institutes for Medical Research in New York in the USA. They discuss their stud...

Screening for cognitive dysfunction in SLE patients from 2021-12-21T16:38:11

Duane Peters from the Lupus Foundation of America interviews Jennifer He from the University of Western Ontario in Canada about her research into using neuropsychological battery tests to determine...

Highlights of ACR Convergence 2021 from 2021-11-23T16:01:15

Duane Peters from the Lupus Foundation of America interviews Dr Jill Buyon, one of LSM's Editors-in-Chief, about the highlights of ACR Convergence 2021, which was held virtually on 3-9 November ...

Personalised metabolite monitoring during pre-conception and pregnancy in SLE patients from 2021-11-17T12:08:50

Duane Peters from the Lupus Foundation of America interviews Francisca Lambert-Fliszar and Dr Evelyne Vinet from McGill University Health Centre in Canada. They discuss monitoring 6-mercaptopurine ...

Can you predict lupus nephritis outcomes using machine learning models? from 2021-10-22T10:09:24

Duane Peters from the Lupus Foundation of America interviews Dr Jim Oates from the Medical University of South Carolina and Ralph H. Johnson VA Medical Center in Charleston, USA. They discuss his p...

Highlights of the LUPUS & CORA 2021 joint congress from 2021-10-13T08:25:50

Duane Peters from the Lupus Foundation of America interviews Dr Ronald von Vollenhoven, one of LSM's Editors-in-Chief, about the highlights of the 14th International Congress on Systemic Lupus E...

Identifying therapeutic targets in lupus nephritis: is obtaining research tissue via biopsy safe? from 2021-10-01T12:13:14

Duane Peters from the Lupus Foundation of America interviews Dr Jill Buyon, one of LSM's Editors-in-Chief, and Dr Philip Carlucci from New York University in the USA, a previous recipient of the LF...

LSM's first Journal Impact Factor™ from 2021-08-31T09:20:40

Duane Peters from the Lupus Foundation of America interviews the Lupus Science&Medicine Editors-in-Chief, Professor Jill Buyon and Professor Ronald van Vollenhoven. They discuss the recent release ...

Can you conduct clinical trials on lupus patients in a home setting? from 2021-07-02T11:34:35

Duane Peters from the Lupus Foundation of America interviews Dr Stephen Balevic, Dr Rachel Randell and Professor Laura Schanberg from Duke University in the USA. They discuss the advantages and cha...

EULAR 2021 eCongress Highlights from 2021-06-08T15:53:50

Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers to discuss the highlights of the lupus research presente...

Safety profile of anifrolumab in SLE patients from 2021-06-01T08:51:31

Duane Peters from the Lupus Foundation of America interviews Professor Eric Morand from Monash University in Australia and Dr Raj Tummala from AstraZeneca in the USA about phase II and III trials o...

The ALPHA Project from 2021-05-04T12:17:18

Duane Peters from the Lupus Foundation of America interviews Dr Susan Manzi from the Allegheny Health Network and Kathleen Arntsen from the Lupus and Allied Diseases Association, both based in the ...

Lupus Academy 10th Annual Meeting Highlights from 2021-04-22T12:07:05

Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers to discuss the highlights of the 10th Annual Meeting of ...

Lupus Academy Tenth Annual Meeting Preview from 2021-04-08T17:00:58

Duane Peters of the Lupus Foundation of America interviews Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers about the 10th Annual Meeting of the Lupus Academy, which wil...

Apolipoprotein L1 risk genotypes in Ghanaian patients from 2021-04-06T14:03:26

Duane Peters from the Lupus Foundation of America interviews Dr Ashira Blazer from New York University, USA, and Dr Ida Dzifa Dey from the University of Ghana in Accra, Ghana, about the association...

Anti-Mu?llerian hormone in African- American women with SLE from 2021-03-03T12:30:20

Duane Peters from the Lupus Foundation of America interviews Ms Meghan Angley and Dr Sam Lim from Emory University in Georgia, and Dr Megan Clowse from Duke University in North Carolina, about infe...

Efficacy and safety of rituximab biosimilar in refractory lupus from 2021-02-04T14:45:34

Duane Peters from the Lupus Foundation of America interviews Dr Pintip Ngamjanyaporn and Dr Nantakarn Pongtarakulpanit from Mahidol University in Bangkok, Thailand, about their study on the short t...

Metabolic syndrome in SLE patients from 2021-01-06T14:36:41

Duane Peters from the Lupus Foundation of America interviews Dr Diane Apostolopoulos and Dr Eric Morand from Monash Health in Australia about their study into the prevalence of metabolic syndrome i...

Validating the use of LFA-REAL to measure disease severity in SLE from 2020-12-16T14:53:23

Duane Peters from the Lupus Foundation of America interviews Dr Manuel Francisco Ugarte-Gil from Peru and Dr Joan Merrill and Dr Anca Askanase from the USA about their study evaluating the use of L...

ANA testing in SLE and autoimmune rheumatic diseases from 2020-11-30T15:27:39

Duane Peters from the Lupus Foundation of America interviews Dr May Choi and Dr Peter Schur from the Lupus Program at Brigham and Women's Hospital in Boston. They discuss the use of the ANA assay f...

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue from 2020-09-02T15:20:47

Duane Peters of the Lupus Foundation of America talks to Elisabet Svenungsson and Helena Idborg from Karolinska Institutet about their published paper: Kynurenine pathway is altered in patients wit...

TNF-? and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus from 2020-08-05T19:34:25

Duane Peters of the Lupus Foundation of America talks to Elisabet Svenungsson and Helena Idborg from Karolinska Institutet about their published paper:TNF-alpha and plasma albumin as biomarkers of ...

Lupus Science & Medicine: what makes it special? from 2020-07-07T14:36:11

Duane Peters from the Lupus Foundation of America interviews Dr Jill Buyon, Professor of Rheumatology at New York University School of Medicine and co-Editor-in-Chief of Lupus Science&Medicine. Dr ...

Anifrolumab effects on rash and arthritis from 2020-07-01T17:16:52

Lupus Science&Medicine Associate Editor Professor Lars Ronnblom talks to Professor Joan T. Merrill from the Oklahoma Medical Research Foundation about her published paper: Anifrolumab effects on ra...

COVID-19 Impact on people with lupus from 2020-06-04T15:32

Dr Jill Buyon, co-Editor in Chief of Lupus, Science&Medicine, explores the lessons we're learning six months into the global pandemic and the impact this is having on lupus patients, the medical...

Lupus, immunity and Covid-19 - Part 2 from 2020-04-12T13:09:11

In the second part of a general update on the effects of Covid-19 in lupus patients, Sara Booth, University of Cambridge, talks to Dr Anca D Askanase, MD, MPH Director, Columbia University Lupus Ce...

Immunity for lupus patients and effects of Covid-19 - Part 1 from 2020-04-08T19:49:26

In this podcast, Sara Booth, University of Cambridge, talks to Professor Sarah Rowlands (Florey Professor of Infection and Immunity,University of Sheffield and Honorary Consultant Physician Nuffiel...

Education and the latest in treatment: reporting from the Lupus Academy 2017 from 2017-06-06T17:28:56

An insight into the important learnings of the Lupus Academy 2017 is brought to you in this special Lupus Science&Medicine podcast. The Editor-in-Chief of the journal Ronald van Vollenhoven, a fou...

Lupus Science and Medicine first year anniversary from 2015-05-22T11:17:21

To mark the first anniversary of Lupus Science and Medicine Harriet Vickers speaks to Dr Ronald van Vollenhoven and Dr Jill Buyon about notable published papers, publishing without an impact fac...

BMJ and the Lupus Foundation of America announce the first open access lupus scientific journal from 2013-10-23T15:47:59

Sandra Raymond, president and CEO of the Lupus Foundation of America, talks about why the foundation wanted to create Lupus Science and Medicine, and what she hopes the journal will achieve.

What to expect from Lupus Science and Medicine from 2013-10-23T15:10:50

The Lupus Foundation of America and BMJ are joining forces to publish Lupus Science and Medicine, the first open access lupus scientific journal.

Joint editor-in-chief Ronald van Vollenhov...